Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 985-1 Sanzo, Higashimura-cho, Fukuyama, Hiroshima, 729-0292, Japan.
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 985-1 Sanzo, Higashimura-cho, Fukuyama, Hiroshima, 729-0292, Japan.
Biochem Biophys Res Commun. 2020 Dec 17;533(4):976-982. doi: 10.1016/j.bbrc.2020.09.114. Epub 2020 Sep 30.
Lysosomal integral membrane protein-2 (LIMP-2) is a type III transmembrane protein that is highly glycosylated and mainly localized to the lysosomal membrane. The diverse functions of LIMP-2 are currently being uncovered; however, its participation in macroautophagy, usually described as autophagy, has not yet been well-investigated. To determine the possible involvement of LIMP-2 in autophagic activity, we examined the intracellular amount of microtubule-associated protein 1 light chain 3 (LC3)-II, which is well-correlated with autophagosome levels, in exogenous rat LIMP-2-expressing COS7 and HEK293 cells. Transient or stable expression of LIMP-2-myc significantly increased the levels of LC3-II. Conversely, knockdown of LIMP-2 decreased the LC3-II levels in NIH3T3 cells. Furthermore, approaches using lysosomal protease inhibitors and mCherry-GFP-LC3 fluorescence suggested that exogenous expression of LIMP-2 increased the biogenesis of autophagosomes rather than decreased the lysosomal turnover of LC3-II. Considering the results of the biochemical assay and the quantitative fluorescence assay together, it is suggested that LIMP-2 has a possible involvement in autophagic activity, especially autophagosome biogenesis.
溶酶体整合膜蛋白-2(LIMP-2)是一种 III 型跨膜蛋白,高度糖基化,主要定位于溶酶体膜。LIMP-2 的多种功能目前正在被揭示;然而,其参与巨自噬(通常称为自噬)的情况尚未得到很好的研究。为了确定 LIMP-2 是否可能参与自噬活性,我们检测了外源性表达大鼠 LIMP-2 的 COS7 和 HEK293 细胞中与自噬体水平密切相关的微管相关蛋白 1 轻链 3(LC3)-II 的细胞内含量。瞬时或稳定表达 LIMP-2-myc 显著增加了 LC3-II 的水平。相反,LIMP-2 的敲低降低了 NIH3T3 细胞中的 LC3-II 水平。此外,使用溶酶体蛋白酶抑制剂和 mCherry-GFP-LC3 荧光的方法表明,外源性表达 LIMP-2 增加了自噬体的生物发生,而不是降低了 LC3-II 的溶酶体周转率。综合生化测定和定量荧光测定的结果表明,LIMP-2 可能参与自噬活性,特别是自噬体的生物发生。